Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1CNS 1Breast 1

Conditions

Meningeal Carcinomatosis 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 6Spinal Puncture 5Specimen Handling 5Methotrexate 3Trastuzumab 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2trastuzumab deruxtecan 1tipifarnib 1sacituzumab govitecan 1paclitaxel-Angiopep-2 conjugate 1merphos 1eribulin 1epothilone B 1Vinorelbine 1Sorafenib 1Referral and Consultation 1Radiation 1Probability 1Physical Examination 1Pemetrexed 1Immunotherapy, Adoptive 1Immunoenzyme Techniques 1Etoposide 1Cytarabine 1Craniospinal Irradiation 1Cisplatin 1Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Meningeal Carcinomatosis × Craniospinal Irradiation × Breast × Clear all
NCT06910761 2025-12-08

Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer

City of Hope Medical Center

Phase 2 Recruiting
35 enrolled
BreastCNSThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡